Quantum BioPharma is trading at $3.90, up 5.27%, with the move appearing primarily sector-driven as biotechnology rose 2.07%.
- No new company-specific announcement was identified on September 23, 2026; the latest press-release page was updated September 22.
- Broader equities traded lower.
- Recent FDA clearance for the Lucid-MS Phase 2 trial and analyst coverage remain supportive background catalysts, but neither is new today.